Absorption and Safety of Topical Timolol to Treat Chronic Wounds

Completed

Conditions studied: Glaucoma, Open-Angle, Chronic Wounds

In brief

Topical timolol has been used primarily as eye drops to treat glaucoma for many years. Recent clinical experience has broadened its off-label use for a number of skin conditions, including slow-healing wounds. While there have been extensive safety studies performed on timolol administration to treat the eye, to date, no studies have documented absorption of timolol after applied on chronic wounds. Thus, the purpose of this study is to determine the blood levels of timolol in patients after topical administration to a chronic wound, and compare these levels with those of patients after administration of the same drug formulation on the eye for the indication of glaucoma.

Key facts

Study ID
NCT04903366
Run by
VA Northern California Health Care System
People needed
40
Starts
2017-11-21
Expected to finish
2020-01-14
Last updated by the study team
2021-05-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.